Aditya Bharadwaj

@adityadoc1

Interventional Cardiologist

Loma Linda University - Loma Linda, United States of America

Assistant Professor of Medicine

Latest contributions

Long‐term safety of paclitaxel drug‐coated balloon‐only angioplasty for de novo coronary artery disease: the SPARTAN DCB study

16 Sep 2020

This study adds to the growing body of evidence demonstrating that DCB is a safe option for the treatment of de novo coronary lesions with NO signal towards increase in mortality up to 5-year follow-up.

Reviewer

Aditya Bharadwaj

Reviewer

Mirvat Alasnag